CBI’s FDA/CMS Summit draws the highest leadership at the FDA and CMS and delivers best available information on FDA and CMS priorities, policy changes, evidence-based practice, federal review processes on various areas of biopharma like CDER, CBER, CDRH and the most cutting-edge advances in healthcare and technology.
Back to All Events
Earlier Event: December 2
ISO/TC 276 WG Meetings
Later Event: December 3
Cell Therapy Manufacturing and Gene Therapy Congress